Skip to main content

Table 1 Study population characteristics (n = 20)

From: Usefulness of an accelerated transoesophageal stress echocardiography in the preoperative evaluation of high risk severely obese subjects awaiting bariatric surgery

Age (years) 50 ± 8
Men/Women 9 (45%)/11 (55%)
Weight (kg) 141 ± 21
BMI (kg/m2) 50 ± 5
Known CAD 1 (5%)
Risk factors for CAD  
   Systemic hypertension 15 (75%)
   Diabetes mellitus 13 (65%)
   Smoking (active or past) 8 (40%)
   Dyslipidemia 13 (65%)
   Positive family history for CAD 3 (15%)
   Sleep apnea 15 (75%)
Abnormal resting ECG 6 (30%)
Medications  
   Aspirin 10 (50%)
   Beta-blockers 5 (25%)
   Calcium channel blockers 5 (25%)
   ACEI/ARB 12 (60%)
   Statins 6 (30%)
   Fibrates 2 (10%)
   Ezetimide 2 (10%)
   Nitrates 1 (5%)
   Diuretics 8 (40%)
   Oral hypoglycaemic agents 9 (45%)
   Insulin 5 (25%)
Baseline blood chemistry  
   Fasting blood glucose (mmol/L) 7.4 ± 3,5
   HbA1c (%) 6.9 ± 1.5
   Total cholesterol (mmol/L) 4.7 ± 1.4
   LDL-cholesterol (mmol/L) 3.1 ± 1.2
   HDL-cholesterol (mmol/L) 1.3 ± 0.2
   Total cholesterol/HDL cholesterol 3.7 ± 1.3
   Triglycerides (mmol/L) 2.0 ± 1.3
  1. ACEI = angiotensin-converting enzyme inhibitors, ARB = angiotensin receptor blockers, BMI = boby mass index, CAD = coronary artery disease, HbA1c = glycated haemoglobin (normal range 4-6%), HDL = high-density lipoprotein, LDL = low-density lipoprotein